Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia

Neurology

Volumn 49, Issue 3, 1997, Pages 779-785

  Katzman, Robert ^a,e   Zhang, M Y ^b   Chen, P J ^a   Gu, N ^b   Jiang, S ^b   Saitoh, T ^a   Chen, X ^a   Klauber, M ^a   Thomas, R G ^a   Liu, W T ^c,d   Yu, E S H ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^d LINGNAN UNIVERSITY   (Hong Kong)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 17644430796     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.3.779     Document Type: Article

References (67)

1. Brousseau T, Legrain S, Berr C, et al. Confirmation of the ∈4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994;44:342-344.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
3. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
4. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120.
5. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-638.
6. Lucotte G, Visvikis S, Leininger-Muler B. Association of apolipoprotein E allele ∈4 with late onset sporadic Alzheimer's disease. Am J Med Genet 1994;54:286-288.
7. Mak Y, Chiu H, Woo J, et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-149.
8. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
9. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
10. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4, and gender. JAMA 1994;271:1316-1317.
11. Pirttila T, Lehtimaki T, Nikkari T, et al. Apolipoprotein E ∈4 allele and risk of dementia. JAMA 1995;273:375-376.
12. Rama Krishnan KR, Ritchie JC Jr, Tupler LA, et al. Apolipoprotein E epsilon 4. Neurology 1994;44:2420-2421.
13. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.
14. Roses AD, Saunders AM, Strittmatter WJ, et al. Association of apolipoprotein E allele ∈4 with late onset familial and sporadic Alzheimer's disease [abstract]. Neurology 1993;43:A192.
15. Sakoda S, Kuriyama M, Osame M, et al. Apolipoprotein E epsilon 4 [abstract]. Neurology 1994;44:A2420.
16. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
17. Schmechel DE, Saunders AM, Strittmatter, et al. Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
18. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
19. Ueki A, Kawano M, Namba Y, et al. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163:166-168.
20. Pericak-Vance MA, Johnson CC, Rimmler JB, et al. Alzheimer disease and apolipoprotein E-4 allele in an Amish population. Ann Neurol 1996;39:700-704.
21. Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 1995;38:463-465.
22. Lannfelt L, Lilius L, Appelgren H, et al. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett 1994;169:175-178.
23. Tsuang D, Kukull W, Sheppard L, et al. Impact of sample selection on APOE ∈4 allele frequency: a comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996;44:704-707.
24. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
25. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
26. Yu ESH, Liu WT, Levy PS, et al. Cognitive impairment among the elderly in Shanghai, China. J Gerontol Soc Sci 1989;44:S97-S106.
27. Zhang M, Katzman R, Jin H, et al. The prevalence of dementia and Alzheimer's disease (AD) in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27:428-437.
28. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993;71:160-165.
29. van Bockxmeer FM, Mamotte CD. Apolipoprotein ∈4 homozygosity in young men with coronary heart disease. Lancet 1992; 340:879-880.
30. Yamamura T, Dong LM, Yamamoto A. Apolipoprotein E polymorphism and coronary heart disease. Chin Med J (Engl) 1992;105:738-741.
31. Katzel LI, Fleg JL, Paidi M, Ragoobarsingh N, Goldberg AP. ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. Arterioscler Thromb 1993;13:1495-1500.
32. Marshall HW, Morrison LC, Wu LL, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease: results of a prospective, angiographically controlled study. Circulation 1994;89:567-577.
33. Asada T, Kariya T, Yamagata Z, Kinoshita M, Asaka A. Apoliprotein E allele in centenarians. Neurology 1996;46:1484.
34. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol 1993;10:27-34.
35. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
36. van Bockxmeer FM. ApoE and ACE genes: impact on human longevity. Nat Genet 1994:6:4-5.
37. Levy PS, Yu ESH, Liu WT, et al. A variation on single-stage cluster sampling used in a survey of elderly people in Shanghai. Int J Epidemiol 1988;17:931-933.
38. Katzman R, Zhang M, Qu W-Y, et al. A Chinese version of the Mini-Mental State Examination: impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988;41:971-978.
39. Salmon DP, Jin H, Zhang MY, et al. Neuropsychological assessment of Chinese elderly in the Shanghai Dementia survey. Clin Neuropsychol 1995;9:1-10.
40. Kawas C, Segal J, Stewart WF, et al. A validation study of the Dementia Questionnaire. Arch Neurol 1994;51:901-906.
41. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley, 1981.
42. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-260.
43. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
44. Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. Am J Hum Genet 1992;51:1311-1324.
45. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
46. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol 1994;36:97-100.
47. Anwar N, Lovestone S, Cheetham ME, et al. Apolipoprotein E-∈4 allele and Alzheimer's disease [letter]. Lancet 1993;342: 1308.
48. Kao JT, Tsai KS, Chang CJ, Huang PC. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995; 114:55-59.
49. Kamboh MI, Bhatia KK, Ferrell RE. Genetic studies of human apolipoproteins. XII. Population genetics of apolipoprotein polymorphisms in Papua, New Guinea. Am J Hum Biol 1990; 2:17-23.
50. Eggertsen G, Tegelman R, Ericsson S, et al. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-2129.
51. James RW, Boemi M, Giansanti R, et al. Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb 1993;13:1456-1459.
52. Cariolou MA, Kokkofitou A, Manoli P, et al. Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus. Genet Epidemiol 1995;12:489-497.
53. Davignon J, Gregg RE, et al. Apolipoprotein E polymorphism and atherosclerosis. Arterioscler Thromb 1988;8:1-24.
54. Kawamata J, Tanaka S, Shimohama S, et al. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994; 57:1414-1416.
55. Frisoni GB, Bianchetti A, Govoni S, et al. Association of apolipoprotein E ∈4 with vascular dementia [letter]. JAMA 1994; 271:1317.
56. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
57. Isoe K, Uarkami K, Sato K, Takashashi K. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996;93:133-137.
58. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484.
59. Roses AD, Saunder AM, Alberts MA, et al. Apolipoprotein E ∈4 alleles and risk of dementia. JAMA 1995;273:374-375.
60. Galasko D, Hansen L, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-895.
61. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoproteint(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphisms. Stroke 1992;23:1557-1562.
62. Olichney JM, Hansen LA, Hofstetter CR, et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
63. Betard C, Robitaille Y, Gee M, Tiberghien D, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5:1893-1896.
64. Kalaria RN, Cohen DL, Premkumar DRD. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. NY Acad Sci 1996;777:266-270.
65. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:1-7.
66. Heinonen O, Lehtovirta M, Soininen H, et al. Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. Neurobiol Aging 1995;16:505-513.
67. Katzman R, Hill LR, Yu ESH, et al. The malignancy of dementia: predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol 1994;51:1220-1225.